TIDMMSYS

RNS Number : 0991K

Microsaic Systems plc

16 September 2016

16 September 2016

Microsaic Systems plc

("Microsaic", "Microsaic Systems" or the "Company")

Change of registered holding of Director's shares

Microsaic Systems plc (AIM: MSYS), the developer of chip-based mass spectrometry instruments, announces that Colin Nicholl, non-executive Chairman of the Company, has transferred 500,000 ordinary shares of 0.25 pence each in the Company ("Ordinary Shares") from the Company's employee share dealing account at N+1 Singer to his account at Schroder & Co. Limited.

There has been no change to Mr Nicholl's beneficial interest in the Company which remains at 4,303,559 Ordinary Shares, representing 2.4% of the issued share capital and total voting rights of the Company.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides additional detail.

 
 Enquiries: 
 Microsaic Systems plc 
  Jim Ramage, CEO 
  Bevan Metcalf, FD                      +44 (0) 1483 751577 
 
   N+1 Singer (Nominated Adviser 
   & Broker) 
   Shaun Dobson 
   Liz Yong                              +44 (0)20 7496 3000 
 Citigate Dewe Rogerson 
  (Financial PR) 
  Mark Swallow, Marine Perrier      +44 (0)20 7282 2948/1068

About Microsaic Systems

Microsaic Systems plc is a high technology company developing chip-based, bench-top mass spectrometry ("MS") instruments that are designed to improve the efficiency of Pharma R&D. MS is an analytical technique of choice for biochemists across many industry sectors.

Microsaic aims to bring routine MS analysis to the pharmaceutical scientist, providing powerful methods of analysis to enable earlier decision making relating to product identification, purity and bioactivity.

The Company is working with established global companies in preparative and purification science with expertise in Pharma and life sciences to co-develop new, integrated and optimised, application-specific, solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines.

The Microsaic 4000 MiD(R), single quadrupole, is the world's smallest MS system, retaining the functionality of larger conventional MS systems, is easier to use by non-specialists, consumes less energy and has lower running costs. The Company is also developing new MS systems, based on its patented chip technologies, to address further areas of emerging need in Pharma R&D.

Microsaic Systems was established in 2001 by a team including founders from Imperial College London, and was admitted to AIM in 2011 (ticker: MSYS).

www.microsaic.com

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1    Details of the person discharging managerial 
       responsibilities / person closely associated 
---  -------------------------------------------------------------- 
 a)   Name                        C J Nicholl 
---  -------------------------  ----------------------------------- 
 2    Reason for the notification 
---  -------------------------------------------------------------- 
 a)   Position/status            PDMR - Non-executive Chairman 
---  -------------------------  ----------------------------------- 
 b)   Initial notification       Initial Notification 
       /Amendment 
---  -------------------------  ----------------------------------- 
 3    Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  -------------------------------------------------------------- 
 a)   Name                       Microsaic Systems plc 
---  -------------------------  ----------------------------------- 
 b)   LEI                        N/A 
---  -------------------------  ----------------------------------- 
 4    Details of the transaction(s): section to 
       be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  -------------------------------------------------------------- 
 a)   Description of 
       the financial               Ordinary shares of 0.25p 
       instrument, type            each 
       of instrument 
                                   GB00B547ZY09 
       Identification 
       code 
---  -------------------------  ----------------------------------- 
 b)   Nature of the              Transfer of ordinary shares 
       transaction                between accounts of the PDMR 
 
                                  No change in beneficial ownership 
---  -------------------------  ----------------------------------- 
 c)   Price(s) and volume(s)       Price(s)    Volume(s) 
                                   ----------  ---------- 
                                    Nil         500,000 
                                   ----------  ---------- 
---  -------------------------  ----------------------------------- 
 d)   Aggregated information 
 
       - Aggregated volume         Not applicable 
 
       - Price 
---  -------------------------  ----------------------------------- 
 e)   Date of the transaction    15 September 2016 
---  -------------------------  ----------------------------------- 
 f)   Place of the transaction   Outside of trading venue 
---  -------------------------  -----------------------------------

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHSFEFEMFMSELU

(END) Dow Jones Newswires

September 16, 2016 08:44 ET (12:44 GMT)